ClinicalTrials.Veeva

Menu

Intellivent ASV in Chronic Obstructive Pulmonary Disease Patients in the ICU

I

Izmir Dr Suat Seren Chest Diseases and Surgery Education and Research Hospital

Status

Completed

Conditions

Chronic Obstructive Pulmonary Disease

Treatments

Device: Intellivent ASV

Study type

Interventional

Funder types

Other

Identifiers

NCT02651935
IGHCEAH-ICU-3

Details and patient eligibility

About

This study will evaluate the effect of a fully closed loop ventilation mode (Intellivent ASV) on the duration of ventilation compared to conventional modes in COPD patients.

Full description

COPD patients often need invasive mechanical ventilation and due to the difficulties in the weaning of these patients, duration of mechanical ventilation can be relatively longer when compared with other ICU patients. Automated systems show promising results in shortening the weaning time in some patient groups. The aim of this study is to evaluate the effect of Intellivent-ASV with Quickwean function on the total duration of invasive mechanical ventilation as a primary outcome. Secondary outcomes are success rate and duration of weaning, ventilator free days at day 28 and intubation free days at day 28 (including NIV) when compared to conventional ventilation with t-piece weaning.

Enrollment

88 patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • COPD patients intubated and mechanically ventilated for less than 24 hours (Including patients who received NIV before intubation)
  • Age > 18 years
  • Written and/or informed consent

Exclusion criteria

  • Septic shock
  • Tracheostomy and/or home mechanical ventilation
  • Expected poor short term prognosis
  • Cardiac arrest with a poor neurological prognosis
  • ARDS
  • Broncho-pleural fistula

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

88 participants in 2 patient groups

Intellivent ASV
Experimental group
Description:
Patients in this arm will be ventilated with Intellivent ASV. Intellivent ASV is an automatic close loop ventilation mode. FiO2 setting will be automatically adjusted according to patients SpO2 and minute volume will be automatically adjusted according to patients EtCO2.
Treatment:
Device: Intellivent ASV
PCV+PSV
No Intervention group
Description:
PCV+PSV is a conventional ventilation strategy of pressure controlled ventilation PCV) and pressure support ventilation (PSV).In this arm, FiO2, pressure control levels, respiratory frequency and all the ventilator settings will be manually adjusted by the physicians in charge.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems